Biologically Active Small Molecules

An internal standard for the quantification of EPEA by GC- or LC-MS.

An internal standard for the quantification of EPEA by GC- or LC-MS.

Eicosapentaenoyl PAF C-16 can be formed by incorporation of EPA into lyso-PAF C-16, as has been demonstrated using neutrophils from monkeys and humans fed a diet enriched in fish oils. Eicosapentaenoyl PAF C-16 can serve as a substrate for PAF C-16

Eicosapentaenoyl PAF C-16 can be formed by incorporation of EPA into lyso-PAF C-16, as has been demonstrated using neutrophils from monkeys and humans fed a diet enriched in fish oils. Eicosapentaenoyl PAF C-16 can serve as a substrate for PAF C-16

Eicosapentaenoyl PAF C-16 can be formed by incorporation of EPA into lyso-PAF C-16, as has been demonstrated using neutrophils from monkeys and humans fed a diet enriched in fish oils. Eicosapentaenoyl PAF C-16 can serve as a substrate for PAF C-16

A hybrid molecule patterned after arachidonoyl serotonin the biological effects of eicosapentaenoyl serotonin are unknown.

A hybrid molecule patterned after arachidonoyl serotonin the biological effects of eicosapentaenoyl serotonin are unknown.

A hybrid molecule patterned after arachidonoyl serotonin the biological effects of eicosapentaenoyl serotonin are unknown.

A hybrid molecule patterned after arachidonoyl serotonin the biological effects of eicosapentaenoyl serotonin are unknown.

ETYA is a nonspecific inhibitor of cyclooxygenases and lipoxygenases. ETYA inhibits human platelet 12-LO and COX-1 with IC₅₀ values of 4 &microM and 8 &microM, respectively.

ETYA is a nonspecific inhibitor of cyclooxygenases and lipoxygenases. ETYA inhibits human platelet 12-LO and COX-1 with IC₅₀ values of 4 &microM and 8 &microM, respectively.

ETYA is a nonspecific inhibitor of cyclooxygenases and lipoxygenases. ETYA inhibits human platelet 12-LO and COX-1 with IC₅₀ values of 4 &microM and 8 &microM, respectively.